MUSCLE-INVASIVE BLADDER CARCINOMA
Clinical trials for MUSCLE-INVASIVE BLADDER CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new MUSCLE-INVASIVE BLADDER CARCINOMA trials appear
Sign up with your email to follow new studies for MUSCLE-INVASIVE BLADDER CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Early trial tests virus + drug combo for tough bladder cancers
Disease control CompletedThis small, early-stage study tested the safety of a two-part treatment for muscle-invasive bladder cancer in patients who could not receive standard chemotherapy. The treatment combined a modified cold virus (CG0070) placed directly into the bladder with an immunotherapy drug (n…
Matched conditions: MUSCLE-INVASIVE BLADDER CARCINOMA
Phase: PHASE1 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Mar 16, 2026 15:26 UTC
-
Double attack on tough bladder cancers shows promise
Disease control CompletedThis small pilot study tested whether combining an immunotherapy drug (pembrolizumab) with a specific chemotherapy regimen before surgery could better treat muscle-invasive bladder cancers with unusual cell types. The goal was to see if this combination could shrink or eliminate …
Matched conditions: MUSCLE-INVASIVE BLADDER CARCINOMA
Phase: PHASE2 • Sponsor: University of Washington • Aim: Disease control
Last updated Mar 16, 2026 15:25 UTC
-
Scientists test blood for cancer clues in bladder patients
Knowledge-focused CompletedThis study tested whether a blood test that looks for tiny pieces of cancer DNA could be used to monitor people with muscle-invasive bladder cancer. One participant undergoing standard treatment had their blood and urine collected at different times. The main goal was to see if c…
Matched conditions: MUSCLE-INVASIVE BLADDER CARCINOMA
Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated Mar 13, 2026 15:06 UTC